The 22nd edition of the Advanced International Breast Cancer Course (AIBCC) – Meet the Professor will be held on 17–18 September 2026 in Padua, Italy. The programme will feature an international faculty of leading experts who will present the latest advances in prevention, early diagnosis, and innovative therapeutic strategies, with a focus on improving both survival outcomes and quality of life for breast cancer patients.
Scientific Program
Thursday, September 17th
| 10.30 | Introduction to the Conference |
| 10.45 | ESMO President Elect – Welcome Remark |
SESSION I – HR+/HER2-
| 11.00 | Clinical and biological definition of early and late risk of relapse |
| 11.20 | Navigating adjuvant ET options |
| 11.40 | Opportunities for radiation therapy de-escalation |
| 12.00 | Exploiting endocrine resistance in advanced disease |
| 12.20 | Revisited metastatic algorithm |
| 12.40 | Discussion |
| 13.20 | Lunch |
SESSION II – HER2+
| 14.20 | Turning biological heterogeneity into clinical action |
| 14.40 | Treatment escalation: neoadjuvant vs post-neoadjuvant strategies |
| 15.00 | Redefining 1st line for advanced disease: induction CT vs ADC? Duration? Which maintenance? |
| 15.20 | Discussion |
| 15.40 | Clinical Multidisciplinary Shooting Session 1 – HR+/HER2- and HER2+ |
| 17.00 | Ceremony for the presentation of the University of Padua Award for Advances in Breast Cancer 2026 |
| 17.15 | Lecture of the Awardee |
| 18.00 | Adjourn |
Friday, September 18th
SESSION III– TNBC
| 9.00 | Markers of sensitivity/resistance to immunotherapy |
| 9.20 | Balancing escalation and de-escalation in eTNBC |
| 9.40 | 1st line PD-L1+: ADC + ICI for all? |
| 10.00 | Discussion |
| 10.20 | Coffee break |
SESSION IV– ROUND TABLE DISCUSSION: FOCUS ON YOUNG WOMEN
| 10.50 | Ferility and pregnancy Hereditary syndromes Surgical management |
| 12.00 | Discussion |
| 12.30 | Lunch |
SESSION V – HOT TOPICS
| 13.30 | Clinical implications of liquid biopsy: MRD, monitoring, guide for target treatment |
| 13.50 | AI applied to histopathology |
| 14.10 | Dealing with new patterns of toxicity |
| 14.30 | The right to be forgotten: Ending Discrimination Against Cancer Survivors |
| 14.50 | Discussion |
| 15.20 | Clinical Multidisciplinary Shooting Session 2 – TNBC and special situations |
| 16.40 | Take home messages and adjourn |
Meeting Venue
Via San Francesco, 90 – Padua
The Center is located in the ZTL area. We recommend the Interparking Italia – Via Trieste 50.
Faculty
Directors
Istituto Oncologico Veneto IRCCS
Department of Surgery, Oncology and Gastroenterology, University of Padova (IT)
Department of Radiation Oncology
Iridium Netwerk
University of Antwerp (BE)
University of Barcelona – Barcelona (ES)
Scientific Committee
Bettina Borisch
Institute of Global Health
Geneve (CH)
Maria Vittoria Dieci
Division of Medical Oncology 2
Istituto Oncologico Veneto IRCCS
Department of Surgery, Oncology and Gastroenterology
Padova (IT)
Hesham Ahmed Gaballah Elghazaly
Department of Clinical Oncology and nuclear medicine
University of Ainshams
Cairo (EG)
Jacek Jassem
Department of Oncology and Radiotherapy
Medical University of Gdansk (PL)
Stephen Johnston
NIHR Biomedical Research Centre for Cancer
Royal Marsden NHS Foundation Trust & Institute of Cancer Research
London (UK)
Sibylle Loibl
German Breast Group
University of Frankfurt (DE)
Eleftherios Mamounas
Comprehensive Breast Program
MD Anderson Cancer Center Orlando
Orlando (US)
Fedro Alessandro Peccatori
Department of Medical Oncology
European Institute of Oncology (IEO)
Milano (IT)
Sandra M. Swain
Professor of Medicine, Associate Dean Research Development
Georgetown University Medical Center
Washington (US)
